Stockscreener 앱 받기
0.7711
1.58%
-0.0124
전일 마감가:
$0.7835
열려 있는:
$0.76
하루 거래량:
79,258
Relative Volume:
0.04
시가총액:
$4.23M
수익:
-
순이익/손실:
$-8.72M
주가수익비율:
-0.1405
EPS:
-5.4871
순현금흐름:
$-5.47M
1주 성능:
-7.43%
1개월 성능:
-21.30%
6개월 성능:
-64.79%
1년 성능:
-73.68%
1일 변동 폭
$0.76
$0.7965
1주일 범위
$0.76
$0.88
52주 변동 폭
$0.7311
$3.50
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
GLMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
0.7711 | 4.29M | 0 | -8.72M | -5.47M | -5.4871 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-05-22 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | 개시 | Craig Hallum | Buy |
| 2020-01-30 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-12-02 | 개시 | Canaccord Genuity | Buy |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-08-02 | 재확인 | Maxim Group | Buy |
| 2018-07-13 | 개시 | Stifel | Buy |
| 2018-07-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-06-12 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-15 | 업그레이드 | Maxim Group | Hold → Buy |
| 2018-02-14 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-02-12 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 개시 | ROTH Capital | Buy |
| 2017-08-08 | 재확인 | H.C. Wainwright | Buy |
| 2017-07-31 | 재확인 | Maxim Group | Buy |
| 2016-08-01 | 재확인 | Maxim Group | Buy |
| 2016-07-06 | 재개 | ROTH Capital | Buy |
| 2016-03-28 | 재개 | H.C. Wainwright | Buy |
| 2015-06-23 | 개시 | H.C. Wainwright | Buy |
| 2015-05-06 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Galmed Pharmaceuticals Ltd 주식(GLMD)의 최신 뉴스
Market Review: Can Home Bancorp Inc maintain its current growth rateQuarterly Portfolio Summary & Consistent Profit Alerts - baoquankhu1.vn
How volatile is Galmed Pharmaceuticals Ltd stockTrade Analysis Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Price Action: What are IBKRs technical support levelsQuarterly Trade Report & Short-Term High Return Strategies - baoquankhu1.vn
Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Crosses Below 50-Day Moving Average – Should You Sell? - Defense World
Trade Recap: Is Galmed Pharmaceuticals Ltd stock a good dividend stock2025 Analyst Calls & Long-Term Growth Stock Strategies - baoquankhu1.vn
Chart Watch: Will Galmed Pharmaceuticals Ltd benefit from government policyWeekly Investment Report & Smart Investment Allocation Insights - baoquankhu1.vn
Stock Report: Is Galmed Pharmaceuticals Ltd in a long term uptrendJuly 2025 Market Mood & Daily Growth Stock Tips - baoquankhu1.vn
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting - MSN
Volume Report: How Galmed Pharmaceuticals Ltd GPH stock expands through international marketsPortfolio Value Report & Free Verified High Yield Trade Plans - Bộ Nội Vụ
Will Galmed Pharmaceuticals Ltd. stock outperform Dow Jones indexPortfolio Value Report & Verified Short-Term Plans - ulpravda.ru
What makes Galmed Pharmaceuticals Ltd. (GPH) stock appealing to growth investorsMarket Risk Analysis & Fast Exit and Entry Trade Guides - Улправда
What technical charts say about Galmed Pharmaceuticals Ltd. stockMarket Performance Summary & Stepwise Entry and Exit Trade Signals - ulpravda.ru
How Galmed Pharmaceuticals Ltd. stock reacts to job market data2025 Performance Recap & Low Drawdown Momentum Ideas - Улправда
Can Galmed Pharmaceuticals Ltd. stock surprise with earnings upsideJuly 2025 Big Picture & Advanced Swing Trade Entry Alerts - Улправда
How Galmed Pharmaceuticals Ltd. (GPH) stock expands through international marketsJuly 2025 Review & Free Technical Confirmation Trade Alerts - Улправда
Is Galmed Pharmaceuticals Ltd. (GPH) stock worth buying before Fed actionJuly 2025 Drop Watch & Smart Investment Allocation Insights - Улправда
Published on: 2026-01-09 00:35:39 - ulpravda.ru
Galmed Pharmaceuticals Ltd.Ordinary Shares (NQ: GLMD - FinancialContent
GLMD Stock Price, Forecast & Analysis | GALMED PHARMACEUTICALS LTD (NASDAQ:GLMD) - Chartmill
What drives Galmed Pharmaceuticals Ltd GPH stock priceTrade Execution Strategies & Small Capital Investment Tips - Early Times
EBIT per share of Galmed Pharmaceuticals Ltd. – BER:GPH - TradingView — Track All Markets
Will Galmed Pharmaceuticals Ltd. stock outperform tech sector in 2025Market Sentiment Surveys & Free Rapid Wealth Multiplication - bollywoodhelpline.com
Is Galmed Pharmaceuticals Ltd. stock a defensive play in 2025Evening Star Patterns & High Profit Market Ideas - bollywoodhelpline.com
Downgrade Watch: Why Galmed Pharmaceuticals Ltd stock is seen as undervalued2025 Short Interest & Weekly Breakout Stock Alerts - Bộ Nội Vụ
Financial Survey: Galmed Pharmaceuticals (NASDAQ:GLMD) vs. Qualigen Therapeutics (NASDAQ:QLGN) - Defense World
Will Galmed Pharmaceuticals Ltd. stock benefit from upcoming earnings reportsJuly 2025 Review & Low Drawdown Investment Strategies - Улправда
Aug Selloffs: How interest rate cuts could boost Galmed Pharmaceuticals Ltd. stock2025 Key Lessons & Long-Term Growth Portfolio Plans - Улправда
How interest rate cuts could boost Galmed Pharmaceuticals Ltd. stock2025 Price Action Summary & Daily Stock Trend Watchlist - Улправда
Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World
How big funds are accumulating Galmed Pharmaceuticals Ltd. (GPH) stockMarket Capitalization Trends & Outperform the Market with Aggressive Picks - Bollywood Helpline
Is Galmed Pharmaceuticals Ltd. (GPH) stock a safe buy pre earningsMarket Trend Review & Weekly Top Gainers Trade List - DonanımHaber
Galmed to present data on Aramchol’s potential in liver cancer By Investing.com - Investing.com Canada
Galmed to present data on Aramchol’s potential in liver cancer - Investing.com
Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation - TipRanks
Galmed Pharmaceuticals’ Aramchol abstract accepted for HEP-DART 2025 presentation - MSN
Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting - PR Newswire
Galmed receives patent for combination therapy in South Korea By Investing.com - Investing.com Nigeria
Can Galmed Pharmaceuticals Ltd. (GPH) stock surprise with quarterly resultsBuy Signal & Weekly Breakout Watchlists - Newser
Galmed Announces Grant of New Use Patents for the Combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra for Mash - marketscreener.com
Galmed stock rises after patent grant for MASH combo therapy By Investing.com - Investing.com Nigeria
Galmed Pharmaceuticals Ltd (GLMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):